(0.04%) 5 310.41 points
(0.05%) 39 826 points
(0.03%) 16 799 points
(-1.44%) $78.65
(-1.02%) $2.72
(-0.59%) $2 424.10
(-1.33%) $32.00
(-0.26%) $1 060.90
(0.07%) $0.921
(-0.21%) $10.67
(0.00%) $0.787
(-0.39%) $90.32
1.67% $ 0.280
Live Chart Being Loaded With Signals
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma...
Stats | |
---|---|
Dzisiejszy wolumen | 31 126.00 |
Średni wolumen | 467 487 |
Kapitalizacja rynkowa | 6.61M |
EPS | $0 ( 2024-03-25 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.760 |
ATR14 | $0.0100 (3.70%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2013-11-04 | Austin Josiah T | Sell | 25 400 | Sponsored ADRs, each convertible into 25 ordinary shares |
2013-11-05 | Austin Josiah T | Sell | 23 922 | Sponsored ADRs, each convertible into 25 ordinary shares |
2013-10-25 | Austin Josiah T | Sell | 62 591 | Sponsored ADRs, each convertible into 25 ordinary shares |
2013-10-28 | Austin Josiah T | Sell | 37 409 | Sponsored ADRs, each convertible into 25 ordinary shares |
2013-10-29 | Austin Josiah T | Sell | 1 100 | Sponsored ADRs, each convertible into 25 ordinary shares |
INSIDER POWER |
---|
0.00 |
Last 100 transactions |
Buy: 5 568 614 | Sell: 243 947 |
Wolumen Korelacja
Kazia Therapeutics Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kazia Therapeutics Korelacja - Waluta/Towar
Kazia Therapeutics Finanse
Annual | 2023 |
Przychody: | $555.00 |
Zysk brutto: | $555.00 (100.00 %) |
EPS: | $-1.120 |
FY | 2023 |
Przychody: | $555.00 |
Zysk brutto: | $555.00 (100.00 %) |
EPS: | $-1.120 |
FY | 2022 |
Przychody: | $25.00 |
Zysk brutto: | $25.00 (100.00 %) |
EPS: | $-1.860 |
FY | 2021 |
Przychody: | $15.18M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.716 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Kazia Therapeutics
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej